Monitoring nicotine intake from e-cigarettes: Measurement of parent drug and metabolites in oral fluid and plasma

Clinical Chemistry and Laboratory Medicine

Volumn 55, Issue 3, 2017, Pages 415-423

  Papaseit, Esther ^a,b,c   Farré, Magí ^a,b,c   Graziano, Silvia ^d   Pacifici, Roberta ^d   Pérez Mañá, Clara ^a   García Algar, Oscar ^a,b   Pichini, Simona ^d  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

cotinine; e cig; nicotine; oral fluid; pharmacokinetics; plasma; trans 3 hydroxycotinine

Indexed keywords

3' HYDROXYCOTININE; COTININE; NICOTINE; BIOLOGICAL MARKER;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG SALIVA LEVEL; ELECTRONIC CIGARETTE; HUMAN; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIME TO MAXIMUM PLASMA CONCENTRATION; YOUNG ADULT; CHEMISTRY; LIQUID CHROMATOGRAPHY; METABOLISM; PLASMA; SALIVA; TANDEM MASS SPECTROMETRY;

BIOMARKERS; CHROMATOGRAPHY, LIQUID; CROSS-OVER STUDIES; ELECTRONIC CIGARETTES; HUMANS; NICOTINE; PLASMA; SALIVA; TANDEM MASS SPECTROMETRY;

EID: 85012903461     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2016-0405     Document Type: Article

References (36)

1. World Health Organization (WHO). WHO global report on trends in tobacco smoking 2000-2025. Available at: http://apps.who.int/ iris/bitstream/10665/156262/1/9789241564922-eng.pdf?ua=1. Accessed: 29 July 2015.
2. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf 2014;5:67-86.
3. Vaz-Carneiro A, Costa J. Analysis of the cochrane review: electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev 2014;12:CD010216.
4. Rom O, Pecorelli A, Valacchi G, Reznick AZ. Are E-cigarettes a safe and good alternative to cigarette smoking? Ann N Y Acad Sci 2015;1340:65-74.
5. Dawkins L, Kimber C, Puwanesarasa Y, Soar K. First-versus second-generation electronic cigarettes: predictors of choice and effects on urge to smoke and withdrawal symptoms. Addiction 2015;110:669-77.
6. Schroeder MJ, Hoffman AC. Electronic cigarettes and nicotine clinical pharmacology. Tob Control 2014;23:ii30-5.
7. Farsalinos KE, Yannovits N, Sarri T, Voudris V, Poulas K. Protocol proposal for, and evaluation of, consistency in nicotine delivery from the liquid to the aerosol of electronic cigarettes atomizers: regulatory implications. Addiction 2016;111:1069-76.
8. Ordonez J, Forrester MB, Kleinschmidt K. Electronic cigarette exposures reported to poison centers. Clin Toxicology 2013;51:685.
9. Harrell PT, Simmons VN, Correa JB, Padhya TA, Brandon TH. Electronic nicotine delivery systems ("e-cigarettes"): review of safety and smoking cessation efficacy. Otolaryngol Head Neck Surg 2014;151:381-93.
10. Drummond MB, Upson D. Electronic cigarettes. Potential harms and benefits. Ann Am Thorac Soc 2014;11:236-42.
11. Chen BC, Bright SB, Trivedi AR, Valento M. Death following intentional ingestion of e-liquid. Clin Toxicol (Phila) 2015;53:914-6.
12. Christensen LB, Van't Veen T, Bang J. Three cases of attempted suicide by ingestion of nicotine liquid used in e-cigarettes. Clin Toxicology 2013;51:290.
13. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine Tob Res 2013;15:158-66.
14. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res 2013;15:267-70.
15. Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology 2014;231:401-7.
16. Behar RZ, Hua M, Talbot P. Puffing topography and nicotine intake of electronic cigarette users. PLoS One 2015;10:e0117222.
17. Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control 2010;19:98-103.
18. Eissenberg T. Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration. Tob Control 2010;19:87-8.
19. Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev 2010;19:1945-53.
20. Vansickel AR, Weaver MF, Eissenberg T. Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction 2012;107:1493-500.
21. Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kostikas K, Tzatzarakis MN, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 2013;25:91-101.
22. Etter JF, Bullen C. Saliva cotinine levels in users of electronic cigarettes. Eur Respir J 2011;38:1219-20.
23. Etter JF. Levels of saliva cotinine in electronic cigarette users. Addiction 2014;109:825-9.
24. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 2013;8:e66317.
25. Concheiro M, Gray TR, Shakleya DM, Huestis MA. Highthroughput simultaneous analysis of buprenorphine, methadone, cocaine, opiates, nicotine, and metabolites in oral fluid by liquid chromatography tandem mass spectrometry. Anal Bioanal Chem 2010;398:915-24.
26. Kim I, Wtsadik A, Choo RE, Jones HE, Huestis MA. Usefulness of salivary trans-3′-hydroxycotinine concentration and trans-3′-hydroxycotinine/cotinine ratio as biomarkers of cigarette smoke in pregnant women. J Anal Toxicol 2005;29:689-95.
27. Marchei E, Escuder D, Pallas CR, Garcia-Algar O, Gomez A, Friguls B, et al. Simultaneous analysis of frequently used licit and illicit psychoactive drugs in breast milk by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal 2011;55:309-16.
28. Marchei E, Joya X, Garcia-Algar O, Vall O, Pacifici R, Pichini S. Ultrasensitive detection of nicotine and cotinine in teeth by high-performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2008;22:2609-12.
29. Marchei E, Durgbanshi A, Rossi S, Garcia-Algar O, Zuccaro P, Pichini S. Determination of arecoline (areca nut alkaloid) and nicotine in hair by high-performance liquid chromatography/ electrospray quadrupole mass spectrometry. Rapid Commun Mass Spectrom 2005;19:3416-8.
30. Pacifici R, Pichini S, Graziano S, Pellegrini M, Massaro G, Beatrice F. Successful nicotine intake in medical assisted use of e-cigarettes: a pilot study. Int J Environ Res Public Health 2015;12:7638-46.
31. Yuki D, Kikuchi A, Miura N, Kakehi A, Onozawa M. Good relationship between saliva cotinine kinetics and plasma cotinine kinetics after smoking one cigarette. Regul Toxicol Pharmacol 2013;67:240-5.
32. Kidwell D, Holland J, Athanaselis S. Testing for drugs of abuse in saliva and sweat. J Chromatogr B 1998;713:111-35.
33. Farsalinos KE, Spyrou A, Stefopoulos C, Tsimopoulou K, Kourkoveli P, Tsiapras D, et al. Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naive users (smokers). Sci Rep 2015;5:11269.
34. Benowitz NL, Hukkanen J, Jacob P 3rd. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol 2009;192:29-60.
35. Benowitz NL, Jacob P 3rd, Fong I, Gupta S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther 1994;268:296-303.
36. Zevin S, Jacob P 3rd, Benowitz N. Cotinine effects on nicotine metabolism. Clin Pharmacol Ther 1997;61:649-54.